NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000056867

Registered date:30/01/2025

Exploratory Study on the Effect of Food Ingredient Intake on Postprandial Blood Glucose Levels -Open-Label Crossover Study-

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedNot applicable
Date of first enrollment2025/01/31
Target sample size24
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns. Test foods: A total of three types Intake method: Each combination of test foods will be consumed once. *The test food combinations are divided into six patterns.

Outcome(s)

Primary OutcomeCmax of blood glucose
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum30years-old
Age maximum64years-old
GenderMale and Female
Include criteria
Exclude criteria(1) Subjects who regularly consume pharmaceuticals or quasi-drugs that may affect the efficacy evaluation of the test food (2) Subjects who continuously consume food for specified health use, functional foods, or health foods that may affect the efficacy evaluation of the test food (3) Subjects whose lifestyle is scheduled to change drastically before or after the start of the study (including business trip, travel, etc. that will significantly change the rhythm of their daily life) (4) Subjects who are currently participating in other studies, who have participated in other studies within 4 weeks after their completion, or who are planning to participate in other studies during the study period (except for the specific studies) (5) Other subjects who are judged by the investigator as unsuitable for the study

Related Information

Contact

public contact
Name Ryoko Koizumi
Address 2-14-1, Nihonbashi, Chuo-ku, Tokyo, 103-0027, JAPAN Japan 103-0027
Telephone 03-6777-7789
E-mail food-contact@apoplus.co.jp
Affiliation Apoplus Station Co., Ltd. CRO Department Clinical Operations Division
scientific contact
Name Tadashi Watanabe
Address 1-5-16, Haneda, Ota-ku, Tokyo, 144-0043, JAPAN Japan
Telephone 03-3741-0223
E-mail wnb.cto@gmail.com
Affiliation Watanabe Hospital Surgery